Perrigo Company (PRGO -0.8%) says it's acquired the remaining stake of privately held Cobrek Pharmaceuticals, in a deal worth approximately $45 million on a cash-free and debt-free basis. PRGO has had a collaborative agreement with the company since 2008, after buying an 18% interest to develop and market Cobrek's foam dosage form generic pharmaceutical products.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs